LL-37
peptideevidence: emerging · v1.0.0Description
LL-37 is the only known human cathelicidin-derived peptide (37 amino acids), studied in antimicrobial and innate-immunity research models. Lyophilized powder. Reconstitute with bacteriostatic water for in-vitro research. Store at -20°C. Certificate of Analysis attached to this listing.
Mechanism summary
Host-defense peptide with immune-signaling activity.
Reference details
Route(s)
subcutaneous
Tags
immune, infection_support
Active
yes
Product details · 375
Price
$64.99
Stock
low stock
Mol. weight
4493.3 g/mol
Formula
C205H340N60O53
Purity
≥ 99%
CAS #
154947-66-7
Amino sequence: LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
COA: View certificate (batch TET-4894-A) →
Teton Labs product catalog · research-use compound data.
💉 Dosing — 2 references (verbatim from source · not a recommendation)
Dose
100 mcg SC daily or every other day
Route
subcutaneous
Frequency
daily or every other day
Duration
2-4 weeks
Cycle
Short cycles; reassess
Reconstitution
Reconstitute with bacteriostatic water
Vial
Commonly 5 mg vials
Source: Practitioner Peptide Dosing Reference (commonly published ranges) — Compiled practitioner reference (internal_protocol)Source-backedProvider-reviewed
Dose
100-200 mcg daily (SC); topical per formulation
Route
subcutaneous or oral or topical
Frequency
Once daily, 5 days per week (SC); as directed (topical)
Duration
2-4 weeks, then 2 weeks off
Cycle
Repeatable
Reconstitution
Bacteriostatic water
Source: Peptide Protocol Wiki (peptideprotocolwiki.com) (publication)Source-backedProvider-reviewed
Provider-only reference. This page does not constitute medical advice, a recommendation, or dosing guidance.